| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 334.61 mm | 334.61 mm | 334.61 mm | 334.61 mm | 334.61 mm | 334.61 mm |
| Cash burn (monthly) | (no burn) | 1.45 mm | 49.55 mm | 30.87 mm | 38.33 mm | 29.33 mm |
| Cash used (since last report) | n/a | 5.85 mm | 199.30 mm | 124.18 mm | 154.16 mm | 117.96 mm |
| Cash remaining | n/a | 328.75 mm | 135.31 mm | 210.43 mm | 180.44 mm | 216.64 mm |
| Runway (months of cash) | n/a | 226.0 | 2.7 | 6.8 | 4.7 | 7.4 |
| 13F holders | Current |
|---|---|
| Total holders | 352 |
| Opened positions | 53 |
| Closed positions | 57 |
| Increased positions | 127 |
| Reduced positions | 108 |
| 13F shares | Current |
|---|---|
| Total value | 5.39 tn |
| Total shares | 169.11 mm |
| Total puts | 581.60 k |
| Total calls | 861.60 k |
| Total put/call ratio | 0.7 |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 22.48 mm | $900.53 bn |
| Vanguard | 15.06 mm | $603.13 bn |
| T. Rowe Price Investment Management | 14.17 mm | $567.58 mm |
| BlackRock | 10.81 mm | $433.17 bn |
| Wellington Management | 8.74 mm | $349.96 bn |
| BLVGF Bellevue | 7.87 mm | $315.45 bn |
| BBBOF BB Biotech | 7.85 mm | $308.19 mm |
| Capital World Investors | 7.83 mm | $313.60 bn |
| BIIB Biogen | 5.75 mm | $347.39 mm |
| STT State Street | 4.85 mm | $194.30 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 16 Jan 25 | Joseph Baroldi | Common Stock | Sell | Dispose S | Yes | No | 32.7 | 1,029 | 33.65 k | 3,071 |
| 16 Jan 25 | Joseph Baroldi | Common Stock | Sell | Dispose S | No | No | 32.7 | 3,401 | 111.21 k | 25,017 |
| 16 Jan 25 | Shannon L. Devers | Common Stock | Sell | Dispose S | No | No | 32.776 | 4,267 | 139.86 k | 15,937 |
| 16 Jan 25 | Richard S Geary | Common Stock | Sell | Dispose S | No | No | 32.863 | 7,072 | 232.41 k | 96,663 |
| 16 Jan 25 | Eugene Schneider | Common Stock | Sell | Dispose S | No | No | 32.79 | 6,523 | 213.89 k | 58,508 |
| 16 Jan 25 | Patrick R. O'neil | Common Stock | Sell | Dispose S | No | No | 32.83 | 7,360 | 241.63 k | 61,203 |
| 15 Jan 25 | Joseph Baroldi | Common Stock | Option exercise | Acquire M | Yes | No | 0 | 2,460 | 0.00 | 4,100 |
| 15 Jan 25 | Joseph Baroldi | Common Stock | Option exercise | Acquire M | No | No | 0 | 8,787 | 0.00 | 28,418 |
| 15 Jan 25 | Joseph Baroldi | RSU Common Stock | Option exercise | Dispose M | Yes | No | 0 | 2,460 | 0.00 | 8,324 |
| 15 Jan 25 | Joseph Baroldi | RSU Common Stock | Grant | Acquire A | Yes | No | 0 | 3,750 | 0.00 | 10,784 |
